AI-generated summary
This protocol describes a planned three-arm, randomised, placebo-controlled, double-blinded study of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer who have chronic xerostomia after radiotherapy. The authors plan to compare two PBM doses (7.5 J/cm2 and 3 J/cm2) with placebo, with about 20 patients per arm. No results are reported, as this is a study protocol.
- Who or what was studied
- Patients with head and neck cancer suffering from chronic xerostomia after radiotherapy
- Limits stated in the abstract
- The abstract reports a study protocol only, so no outcomes or effects are available, and the abstract states the evidence for PBM in this setting is low to moderate quality.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 7.5 J/cm2, 3 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Placebo-controlled, Photobiomodulation therapy, Trial registration, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.